| 摘要 |
PROBLEM TO BE SOLVED: To provide improved compositions that modulate PKC activity to help treat skin wounds and other chronic wounds.SOLUTION: The present disclosure relates to compositions for accelerating a healing process of wounds, increasing the closure of skin wounds, and decreasing inflammation at the site of a skin wound. Specifically, the disclosure relates to compositions comprising a δ-PKC activator, an α-PKC inhibitor, and a pharmaceutically acceptable carrier that is free of Caand Mgcations. The disclosure also relates to compositions comprising an insulin or insulin analog and a pharmaceutically acceptable carrier that is free of Caand Mgcations. |
